590 likes | 724 Views
One drug, two stories. Dr FT Lee PMH/YCH AED. History (Patient A). 8-1-05 02:12 F/49 Known case of CRHD with MVR FU GH On Digoxin, Lasix, Acertil, Slow K. Aldactone, Warfarin. Attempt suicide with her husband by taking
E N D
One drug, two stories Dr FT Lee PMH/YCH AED
History (Patient A) • 8-1-05 02:12 • F/49 • Known case of CRHD with MVR FU GH • On Digoxin, Lasix, Acertil, Slow K. Aldactone, Warfarin
Attempt suicide with her husband by taking Digoxin >100 tablets (0.25mg/tablet) & Acertil > 60 tablets at around 01:00 (1 hour before arrival) • Vomit twice
P/E: • GCS: 14-15, refused to cooperate • BP: 152/49, P:49/min • RR:22/min, SaO2: 98% (Rm air) • Temp: 36°C • H’stix: 8.3
Management in AED • 100%O2 • Cardiac monitor • NS Q4H • CXR: cardiomegaly • Consult ICU • Standby pacing • Transfer to ICU at 02:30 (13 mins) • BP:166/70, P:30/min
Progress in ICU • Cardiac arrest at 02:50(38 mins) • Pulseless VT • Defibrillate 150J then 200J Asystole • TCP given but no cardiac output • Certified dead after 1 hr of active resuscitation • Adrenaline 1mg x 7 • Atropine 0.6mg x2 • NaHCO3 100ml
Digitalis antidote was ordered but only available after prolonged resuscitation • RFT: Na: 131, K: 7.3, Urea: 7.4, Cr: 88 • INR: 1.6
History (Patient B) • M/58 (Husband) • Good past health • Attempt suicide with his wife by taking Digoxin > 60 tabs, Acertil > 100 Tabs, Warfarin > 100 tabs, Piriton> 60 Tabs at 01:00 • Vomit
P/E • GCS: 15 • BP: 151/65, P: 93/min • RR: 16/min, Sa O2: 99% (Rm air) • Temp: 37°C
Management in AED • O2 • NS Q4H • Cardiac Monitor • CXR: NAD • Activated charcoal 50g po • Consult ICU (Suggest admission to Medical ward)
Progress • Transfer to ICU at 05:40 (BP: 160/80, P: 100/min) • RFT: Na: 135, K: 4.8, Urea: 7.2, Cr: 90 • INR: 1.5 • 11:20 (10 hrs postingestion) P: 35-40/min, BP: 140/60, ECG: Complete Heart Block Atropine 0.6mg iv Transvenous pacing
11:25, 10 hrs postingestion Digoxin Level 10.7 nmol/l (1.3-2.6) • 13:45 (12 hrs postingestion) Digitalis Fab 480mg(6 vials) was given over ½ hour • 20:40 (7 hrs after Fab) Urticaria Piriton 10mg iv ECG: SR, 100/min
09-01-2005 (Day 2) INR: 2.8 • off pacing • Vit K1 10mg iv
Digoxin Level Digitalis antidote
Progress • To general medical ward on D3 • Claimed that he would commit suicide again • Psychiatric assessment: Adjustment disorder • Transfer to KCH by Vol form on D16
Mechanism • Inhibition of the Na-K-ATPase pump (70%)
Normal depolarization & repolarization Depolarization Na-K-ATPase pump Na & Ca Ca
Toxic Digoxin effect Elevate the resting potential predispose to dysrhythmia
Toxic Digoxin effect (Autonom & Anta Pharm, Vol 25(2) 35-52)
Rhythm disturbances • Increase automaticity particularly in the Purkinje fibre • Impaired conduction through the SA & AV node
Extracardiac • Nausea, vomiting almost always present • Confusion and delirium • Seizure (very rare)
Toxicokinetic • Toxic dose: >3mg in Adults >1mg in Child • Large volume of distribution (Vd: 5-10 l/kg)
Toxicokinetic • Two-compartment system ka k12 Compartment 1 (Serum) Compartment 2 (Tissue) k21 kel
Toxicokinetic • Peak effect occurs after a delay of 6-12 hours • Eliminated by kidney (60-80%) • Elimination half-life: 1.6 days
Hyperkalaemia • An accurate predictor of outcome (Bismuth et al; J Toxicol Clin Toxicol 6: 153-162, 1973)
Digoxin Level • Tissue distribution completes in 6-12 hours • Not correlate accurately with severity of intoxication • Other metabolic abnormalities must take into consideration • Falsely elevated after Digibind
Management • ABC • Decontamination • Antidote
Treatment of dysrhythmia • Bradydysrhythmias • Atropine • Caution with electrical pacing • Trigger fatal arrhythmia or delay Fab • Failed in 23% of patient (vs 8% treated with Digibind) • Iatrogenic accidents in 36% vs 0% in Digibind (p<0.05) (Taboulet et al; J Toxicol Clin Toxicol 31: 261-273, 1993)
Treatment of dysrhythmia • Tachydysrhythmia • Cardioversion may precipitate refractory VT, VF or asystole • Start with very low energy (10-25J) • Pretreated with Lidocaine or Amiodarone • Digitalis Fab
GI decontamination • Orogastric larvage • increase vagal tone • Activated Charcoal • Multiple dose Activated Charcoal is effective (Silva et al; Lancet 2003;361:1935-38)
Treatment of Hyperkalaemia • K>5mmol/l is an absolute indication for Digibind (Elliot et al; Circulation 1990;81;1744-52)
Treatment of Hyperkalaemia • Insulin/glucose, NaHCO3 • Ca must not be given except after Digibind • Correction of hyperkalaemia does not improve survival (Bismuth et al; J Toxicol Clin Toxicol 6: 153-162, 1973)
Digoxin Immune Fab • Produced in immunize sheep • Greater binding affinity for digoxin than Na-K ATPase • Fab fragment-digoxincomplex eliminated through kidney (T1/2: 15-20 hrs)
Pharmakokinetic • Creates a concentration gradient to dissociate digoxin from the heart Compartment 2 Digoxin at Myocardial receptor Compartment 1 Serum & Intersitial free Digoxin Increase renal clearance by 20-30%
Effectiveness • Resolution of all signs/symptoms (80%) • Improvement (10%) • No response (10%) • Response within 1 hour (mean:19 mins) and complete within 4 hours (TW. Smith American J of Emerg Med, March 191:1-6)
Decrease mortality (Antman et al; Circulation 1990;81;1744-52)
Improve survival rate in digitalis-induced cardiac arrest (Gaultier et al La Rev d Practicien 1978; 28:4565-4579) (Elliot et al; Circulation 1990;81;1744-52)
Indications • Rhythm & Conduction disturbances • Hyperkalaemia (>5mmol/l) • Digoxin ingestion >10mg (>4mg in child) • Serum digoxin level 15ng/ml (19nmol/l) at any time or >10ng/ml (13nmol/l) 6h postingestion
Factors affecting the efficacy • Time of administration • Dosage • Rate of administration
Dosage • Amount of ingestion and post distribution Digoxin level is unknown • Amount of ingestion is known • Post distribution Digoxin level is known
Dosage • The brand of Digoxin Fab
Digitalis Antidote (Roche) Available in PMH 80mg/vial Each vial binds 1 mg digoxin Digibind (Glaxo) 38mg/vial Each vial binds 0.5mg digoxin